HCMT
ELV icon

Highland Capital Management (Tennessee)’s Elevance Health ELV Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Sell
1,180
-20
-2% -$7.42K 0.02% 329
2026
Q1 		$351K Hold
1,200
– – 0.02% 355
2025
Q4 		$421K Hold
1,200
– – 0.02% 296
2025
Q3 		$388K Hold
1,200
– – 0.02% 306
2025
Q2 		$467K Hold
1,200
– – 0.03% 281
2025
Q1 		$522K Hold
1,200
– – 0.03% 271
2024
Q4 		$443K Hold
1,200
– – 0.03% 276
2024
Q3 		$624K Hold
1,200
– – 0.04% 265
2024
Q2 		$650K Hold
1,200
– – 0.04% 246
2024
Q1 		$622K Sell
1,200
-17,384
-94% -$8.65M 0.04% 265
2023
Q4 		$8.76M Buy
18,584
+120
+0.6% +$55.5K 0.54% 41
2023
Q3 		$8.04M Sell
18,464
-1,610
-8% -$730K 0.55% 40
2023
Q2 		$8.92M Sell
20,074
-335
-2% -$155K 0.58% 40
2023
Q1 		$9.38M Sell
20,409
-87
-0.4% -$41.4K 0.69% 40
2022
Q4 		$10.5M Sell
20,496
-60
-0.3% -$30.5K 0.74% 29
2022
Q3 		$9.34M Sell
20,556
-30
-0.1% -$14.4K 0.72% 30
2022
Q2 		$9.93M Sell
20,586
-100
-0.5% -$49.5K 0.71% 35
2022
Q1 		$10.2M Sell
20,686
-40
-0.2% -$18.3K 0.61% 38
2021
Q4 		$9.61M Sell
20,726
-210
-1% -$88.3K 0.54% 47
2021
Q3 		$7.8M Sell
20,936
-550
-3% -$209K 0.47% 56
2021
Q2 		$8.2M Sell
21,486
-410
-2% -$157K 0.49% 56
2021
Q1 		$7.86M Sell
21,896
-1,790
-8% -$576K 0.49% 60
2020
Q4 		$7.61M Sell
23,686
-538
-2% -$165K 0.49% 54
2020
Q3 		$6.51M Sell
24,224
-631
-3% -$170K 0.47% 62
2020
Q2 		$6.54M Sell
24,855
-6,129
-20% -$1.64M 0.51% 54
2020
Q1 		$7.04M Buy
30,984
+4,956
+19% +$1.35M 0.66% 40
2019
Q4 		$7.86M Buy
26,028
+5,807
+29% +$1.6M 0.55% 54
2019
Q3 		$4.86M Sell
20,221
-453
-2% -$124K 0.36% 81
2019
Q2 		$5.83M Sell
20,674
-576
-3% -$157K 0.43% 69
2019
Q1 		$6.1M Sell
21,250
-250
-1% -$72.3K 0.46% 62
2018
Q4 		$5.65M Buy
21,500
+200
+0.9% +$55K 0.48% 57
2018
Q3 		$5.84M Sell
21,300
-200
-0.9% -$51.9K 0.42% 70
2018
Q2 		$5.12M Buy
21,500
+100
+0.5% +$23.2K 0.39% 71
2018
Q1 		$4.7M Buy
+21,400
New +$5.03M 0.37% 81
2017
Q2 		– Sell
-1,961
Closed -$324K – 364
2017
Q1 		$324K Buy
+1,961
New +$312K 0.03% 283
2016
Q3 		– Sell
-28,036
Closed -$3.68M – 343
2016
Q2 		$3.68M Sell
28,036
-100
-0.4% -$13.7K 0.32% 94
2016
Q1 		$3.91M Sell
28,136
-68
-0.2% -$9.09K 0.33% 92
2015
Q4 		$3.93M Buy
28,204
+1,245
+5% +$172K 0.32% 102
2015
Q3 		$3.77M Sell
26,959
-19,400
-42% -$2.92M 0.32% 99
2015
Q2 		$7.61M Buy
+46,359
New +$7.41M 0.58% 46

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ELV Position: Q2 2026 in Review

Highland Capital Management (Tennessee) reduced its Elevance Health (ELV) stake by 1.7% in Q2 2026, selling an estimated $7.42K and leaving 1,180 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #329.

Highland Capital Management (Tennessee) first reported a position in ELV in Q2 2015 and has held it in 40 quarters since. The position peaked at $10.5M in Q4 2022. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Highland Capital Management (Tennessee) held 1,180 shares of Elevance Health worth $456K as of Q2 2026.
  • Highland Capital Management (Tennessee) sold 20 Elevance Health shares in Q2 2026, an estimated $7.42K.
  • Elevance Health made up 0.02% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #329 holding.
  • Highland Capital Management (Tennessee) first reported a position in Elevance Health in Q2 2015 and has held it in 40 quarters since.
  • Highland Capital Management (Tennessee)'s Elevance Health position peaked at $10.5M in Q4 2022.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.